Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
VMF
0
Europe
0
Australia
0
South Africa
Regulatory FDF Prices
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


1. Codinovo
2. Dicodid
3. Dihydrocodeinone
4. Hycodan
5. Hycon
6. Hydrocodeinonebitartrate
7. Hydrocodon
8. Hydrocodone
9. Hydrocodone Tartrate (1:1), Hydrate (2:5)
10. Hydrocon
11. Robidone
1. (4r,4ar,7ar,12bs)-9-methoxy-3-methyl-1,2,4,4a,5,6,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one;2,3-dihydroxybutanedioic Acid
2. .codon
3. Schembl154972
4. Chembl2062267
1. Hydrocone
2. Multacodin
3. Hydrocodone
| Molecular Weight | 449.4 g/mol |
|---|---|
| Molecular Formula | C22H27NO9 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 4 |
| Exact Mass | 449.16858144 g/mol |
| Monoisotopic Mass | 449.16858144 g/mol |
| Topological Polar Surface Area | 154 Ų |
| Heavy Atom Count | 32 |
| Formal Charge | 0 |
| Complexity | 642 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 2 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Analgesics, Opioid
Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. (See all compounds classified as Analgesics, Opioid.)
Antitussive Agents
Agents that suppress cough. They act centrally on the medullary cough center. EXPECTORANTS, also used in the treatment of cough, act locally. (See all compounds classified as Antitussive Agents.)
Narcotics
Agents that induce NARCOSIS. Narcotics include agents that cause somnolence or induced sleep (STUPOR); natural or synthetic derivatives of OPIUM or MORPHINE or any substance that has such effects. They are potent inducers of ANALGESIA and OPIOID-RELATED DISORDERS. (See all compounds classified as Narcotics.)
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-04-23
Pay. Date : 2013-04-09
DMF Number : 19848
Submission : 2006-10-03
Status : Active
Type : II
NDC Package Code : 49812-0132
Start Marketing Date : 1996-01-01
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Noramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-02-08
Pay. Date : 2012-11-23
DMF Number : 21158
Submission : 2007-12-18
Status : Active
Type : II
NDC Package Code : 51634-0014
Start Marketing Date : 1987-07-24
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Noramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-03-31
Pay. Date : 2014-03-20
DMF Number : 23681
Submission : 2010-03-31
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17285
Submission : 2004-03-25
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 24846
Submission : 2011-09-30
Status : Active
Type : II

GDUFA
DMF Review : Reviewed
Rev. Date : 2014-06-23
Pay. Date : 2013-11-25
DMF Number : 25961
Submission : 2013-10-31
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 30008
Submission : 2015-12-03
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 4884
Submission : 1983-03-15
Status : Inactive
Type : II
NDC Package Code : 0406-1559
Start Marketing Date : 2011-12-17
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Nosa Chemical Co., Ltd.
Registration Date : 2022-05-25
Registration Number : 20220525-211-J-1305
Manufacturer Name : SpecGx LLC
Manufacturer Address : 3600 North 2nd Street, St. Louis, MO 63147, USA

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us
CAS Number : 3861-72-1
End Use API : Hydrocodone Bitartrate
About The Company : Temad Co., established in 1997, is one of Iran's largest API producers and an innovative manufacturer of narcotic and non-narcotic products in the Middle East. ...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : DISCN
Registration Country : USA
HYDROCODONE BITARTRATE; IBUPROFEN
Brand Name : VICOPROFEN
Dosage Form : TABLET;ORAL
Dosage Strength : 7.5MG;200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1997-09-23
Application Number : 20716
Regulatory Info : DISCN
Registration Country : USA
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : DISCN
Registration Country : USA
ACETAMINOPHEN; HYDROCODONE BITARTRATE
Brand Name : VICODIN HP
Dosage Form : TABLET;ORAL
Dosage Strength : 660MG;10MG
Packaging :
Approval Date : 1996-09-23
Application Number : 40117
Regulatory Info : DISCN
Registration Country : USA
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : DISCN
Registration Country : USA
ACETAMINOPHEN; HYDROCODONE BITARTRATE
Brand Name : VICODIN
Dosage Form : TABLET;ORAL
Dosage Strength : 500MG;5MG
Packaging :
Approval Date : 1983-01-07
Application Number : 88058
Regulatory Info : DISCN
Registration Country : USA
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : DISCN
Registration Country : USA
ACETAMINOPHEN; HYDROCODONE BITARTRATE
Brand Name : VICODIN ES
Dosage Form : TABLET;ORAL
Dosage Strength : 750MG;7.5MG
Packaging :
Approval Date : 1988-12-09
Application Number : 89736
Regulatory Info : DISCN
Registration Country : USA
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Regulatory Info : RX
Registration Country : USA
ASPIRIN; HYDROCODONE BITARTRATE
Brand Name : HYDROCODONE BITARTRATE AND ASPIRIN
Dosage Form : TABLET;ORAL
Dosage Strength : 500MG;5MG
Packaging :
Approval Date : 2021-05-28
Application Number : 205479
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
ACETAMINOPHEN; HYDROCODONE BITARTRATE
Brand Name : HYDROCODONE BITARTRATE AND ACETAMINOPHEN
Dosage Form : TABLET;ORAL
Dosage Strength : 325MG;2.5MG
Packaging :
Approval Date : 2010-06-09
Application Number : 40846
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
ACETAMINOPHEN; HYDROCODONE BITARTRATE
Brand Name : HYDROCODONE BITARTRATE AND ACETAMINOPHEN
Dosage Form : TABLET;ORAL
Dosage Strength : 650MG;5MG
Packaging :
Approval Date : 2010-06-09
Application Number : 40849
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
ACETAMINOPHEN; HYDROCODONE BITARTRATE
Brand Name : HYDROCODONE BITARTRATE AND ACETAMINOPHEN
Dosage Form : SOLUTION;ORAL
Dosage Strength : 300MG/15ML;10MG/15ML
Packaging :
Approval Date : 2010-02-25
Application Number : 40881
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
ACETAMINOPHEN; HYDROCODONE BITARTRATE
Brand Name : HYDROCODONE BITARTRATE AND ACETAMINOPHEN
Dosage Form : SOLUTION;ORAL
Dosage Strength : 500MG/15ML;7.5MG/15ML
Packaging :
Approval Date : 1992-08-28
Application Number : 81051
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
ACETAMINOPHEN; HYDROCODONE BITARTRATE
Brand Name : HYDROCODONE BITARTRATE AND ACETAMINOPHEN
Dosage Form : CAPSULE;ORAL
Dosage Strength : 500MG;5MG
Packaging :
Approval Date : 1989-11-30
Application Number : 81067
Regulatory Info : DISCN
Registration Country : USA
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Regulatory Info :
Registration Country : India
Acetaminophen; Hydrocodone Bitartrate
Brand Name : Acetaminophen; Hydroco...
Dosage Form : Tablet
Dosage Strength : 300MG; 7.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Acetaminophen; Hydrocodone Bitartrate
Dosage : Tablet
Dosage Strength : 300MG; 7.5MG
Brand Name : Acetaminophen; Hydroco...
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Acetaminophen; Hydrocodone Bitartrate
Brand Name : Acetaminophen; Hydroco...
Dosage Form : Tablet
Dosage Strength : 300MG; 10MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Acetaminophen; Hydrocodone Bitartrate
Dosage : Tablet
Dosage Strength : 300MG; 10MG
Brand Name : Acetaminophen; Hydroco...
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Acetaminophen; Hydrocodone Bitartrate
Brand Name : Acetaminophen; Hydroco...
Dosage Form : Tablet
Dosage Strength : 5MG; 325MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Acetaminophen; Hydrocodone Bitartrate
Dosage : Tablet
Dosage Strength : 5MG; 325MG
Brand Name : Acetaminophen; Hydroco...
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Acetaminophen; Hydrocodone Bitartrate
Brand Name : Acetaminophen; Hydroco...
Dosage Form : Tablet
Dosage Strength : 7.5MG; 325MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Acetaminophen; Hydrocodone Bitartrate
Dosage : Tablet
Dosage Strength : 7.5MG; 325MG
Brand Name : Acetaminophen; Hydroco...
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Acetaminophen; Hydrocodone Bitartrate
Brand Name : Acetaminophen; Hydroco...
Dosage Form : Tablet
Dosage Strength : 10MG; 325MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Acetaminophen; Hydrocodone Bitartrate
Dosage : Tablet
Dosage Strength : 10MG; 325MG
Brand Name : Acetaminophen; Hydroco...
Approval Date :
Application Number :
Registration Country : India
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : U.S.A
HYDROCODONE BITARTRATE; Acetaminophen/Paracetamol
Brand Name :
Dosage Form : Tablet
Dosage Strength : 5MG; 325MG
Packaging : Size: 100s, 500s, 100 U.D. (For Size 100 U.D. - Unit Dose Packaging-ten 2x5 blister cards)
Approval Date :
Application Number :
Regulatory Info :
Registration Country : U.S.A

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging : Size: 100s, 500s, 100 U.D. (For Size 100 U.D. - Unit Dose Packaging-ten 2x5 blister cards)
Regulatory Info :
HYDROCODONE BITARTRATE; Acetaminophen/Paracetamol
Dosage : Tablet
Dosage Strength : 5MG; 325MG
Brand Name :
Approval Date :
Application Number :
Registration Country : U.S.A

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : U.S.A
HYDROCODONE BITARTRATE; Acetaminophen/Paracetamol
Brand Name :
Dosage Form : Tablet
Dosage Strength : 7.5MG; 325MG
Packaging : Size: 100s, 500s, 100 U.D. (For Size 100 U.D. - Unit Dose Packaging-ten 2x5 blister cards)
Approval Date :
Application Number :
Regulatory Info :
Registration Country : U.S.A

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging : Size: 100s, 500s, 100 U.D. (For Size 100 U.D. - Unit Dose Packaging-ten 2x5 blister cards)
Regulatory Info :
HYDROCODONE BITARTRATE; Acetaminophen/Paracetamol
Dosage : Tablet
Dosage Strength : 7.5MG; 325MG
Brand Name :
Approval Date :
Application Number :
Registration Country : U.S.A

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : U.S.A
HYDROCODONE BITARTRATE; Acetaminophen/Paracetamol
Brand Name :
Dosage Form : Tablet
Dosage Strength : 10MG; 325MG
Packaging : Size: 100s, 500s, 100 U.D. (For Size 100 U.D. - Unit Dose Packaging-ten 2x5 blister cards)
Approval Date :
Application Number :
Regulatory Info :
Registration Country : U.S.A

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging : Size: 100s, 500s, 100 U.D. (For Size 100 U.D. - Unit Dose Packaging-ten 2x5 blister cards)
Regulatory Info :
HYDROCODONE BITARTRATE; Acetaminophen/Paracetamol
Dosage : Tablet
Dosage Strength : 10MG; 325MG
Brand Name :
Approval Date :
Application Number :
Registration Country : U.S.A

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Specs: USP
Registration Country : U.S.A
Brand Name :
Dosage Form : Powder
Dosage Strength :
Packaging : Size: 5 Gram Bottle
Approval Date :
Application Number :
Regulatory Info : Specs: USP
Registration Country : U.S.A

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging : Size: 5 Gram Bottle
Regulatory Info : Specs: USP
Dosage : Powder
Dosage Strength :
Brand Name :
Approval Date :
Application Number :
Registration Country : U.S.A

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
50
PharmaCompass offers a list of Hydrocodone Bitartrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Hydrocodone Bitartrate manufacturer or Hydrocodone Bitartrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Hydrocodone Bitartrate manufacturer or Hydrocodone Bitartrate supplier.
PharmaCompass also assists you with knowing the Hydrocodone Bitartrate API Price utilized in the formulation of products. Hydrocodone Bitartrate API Price is not always fixed or binding as the Hydrocodone Bitartrate Price is obtained through a variety of data sources. The Hydrocodone Bitartrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A ANEXSIA 5/325-1 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of ANEXSIA 5/325-1, including repackagers and relabelers. The FDA regulates ANEXSIA 5/325-1 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. ANEXSIA 5/325-1 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of ANEXSIA 5/325-1 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A ANEXSIA 5/325-1 supplier is an individual or a company that provides ANEXSIA 5/325-1 active pharmaceutical ingredient (API) or ANEXSIA 5/325-1 finished formulations upon request. The ANEXSIA 5/325-1 suppliers may include ANEXSIA 5/325-1 API manufacturers, exporters, distributors and traders.
click here to find a list of ANEXSIA 5/325-1 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A ANEXSIA 5/325-1 DMF (Drug Master File) is a document detailing the whole manufacturing process of ANEXSIA 5/325-1 active pharmaceutical ingredient (API) in detail. Different forms of ANEXSIA 5/325-1 DMFs exist exist since differing nations have different regulations, such as ANEXSIA 5/325-1 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A ANEXSIA 5/325-1 DMF submitted to regulatory agencies in the US is known as a USDMF. ANEXSIA 5/325-1 USDMF includes data on ANEXSIA 5/325-1's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The ANEXSIA 5/325-1 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of ANEXSIA 5/325-1 suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a ANEXSIA 5/325-1 Drug Master File in Korea (ANEXSIA 5/325-1 KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of ANEXSIA 5/325-1. The MFDS reviews the ANEXSIA 5/325-1 KDMF as part of the drug registration process and uses the information provided in the ANEXSIA 5/325-1 KDMF to evaluate the safety and efficacy of the drug.
After submitting a ANEXSIA 5/325-1 KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their ANEXSIA 5/325-1 API can apply through the Korea Drug Master File (KDMF).
click here to find a list of ANEXSIA 5/325-1 suppliers with KDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing ANEXSIA 5/325-1 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for ANEXSIA 5/325-1 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture ANEXSIA 5/325-1 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain ANEXSIA 5/325-1 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a ANEXSIA 5/325-1 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of ANEXSIA 5/325-1 suppliers with NDC on PharmaCompass.
ANEXSIA 5/325-1 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of ANEXSIA 5/325-1 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right ANEXSIA 5/325-1 GMP manufacturer or ANEXSIA 5/325-1 GMP API supplier for your needs.
A ANEXSIA 5/325-1 CoA (Certificate of Analysis) is a formal document that attests to ANEXSIA 5/325-1's compliance with ANEXSIA 5/325-1 specifications and serves as a tool for batch-level quality control.
ANEXSIA 5/325-1 CoA mostly includes findings from lab analyses of a specific batch. For each ANEXSIA 5/325-1 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
ANEXSIA 5/325-1 may be tested according to a variety of international standards, such as European Pharmacopoeia (ANEXSIA 5/325-1 EP), ANEXSIA 5/325-1 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (ANEXSIA 5/325-1 USP).